Dr. Mark Hyman Longevity Protocol: The Hypothesized Full Supplement, Hormone, and Peptide Stack

Who Is Dr. Mark Hyman and Why Does His Protocol Matter?

Dr. Mark Hyman is a board-certified family physician, a 14-time New York Times bestselling author, and the founder and medical director of the UltraWellness Center in Lenox, Massachusetts. He serves as a senior advisor at the Cleveland Clinic Center for Functional Medicine.

His public profile makes him one of the most cited non-academic voices in longevity medicine, and his willingness to disclose personal health interventions gives clinicians and patients an unusually transparent window into applied functional medicine. That transparency has limits, however. Hyman has never published a peer-reviewed self-report, so everything below is reconstructed from interviews, podcasts, and his own books. Where reconstruction relies on inference rather than a direct statement, this article says so explicitly.

The Foundational Dietary Framework: Pegan Eating and Metabolic Precision

What the Pegan Diet Actually Requires

Hyman coined the term "Pegan" to describe a diet that takes the anti-inflammatory logic of paleo eating and combines it with the plant density of a vegan approach. In practice, 75 percent of the plate is non-starchy vegetables and low-glycemic fruit. The remaining 25 percent is high-quality protein, primarily grass-fed meat, wild-caught fish, and pastured eggs.

Refined grains, added sugar, dairy (with limited exceptions for grass-fed ghee), and industrial seed oils are excluded. The dietary pattern aligns closely with what a 2020 meta-analysis in The BMJ identified as associated with lower all-cause mortality: high vegetable intake, low ultra-processed food consumption, and adequate omega-3 fatty acid supply [1].

Time-Restricted Eating and Fasting Insulin

Hyman has described practicing a 12-to-16-hour overnight fast on most days. He has stated publicly that he targets a fasting insulin level below 5 mcIU/mL, well below the conventional laboratory upper limit of approximately 25 mcIU/mL. Research from Stanford published in JAMA Network Open (N=6,321) found that fasting insulin in the lowest quartile was associated with a 40% lower risk of incident type 2 diabetes over 10 years compared with the highest quartile [2].

Glycemic Monitoring

Hyman has discussed continuous glucose monitor (CGM) use to identify personal glucose excursions after specific foods. CGM-guided dietary personalization has modest trial data: the Weizmann Institute's landmark 2015 Cell study (N=800) showed that post-meal glucose responses to identical foods varied dramatically between individuals, supporting personalized dietary tuning rather than population-average carbohydrate guidelines [3].

The Supplement and Nutraceutical Stack

Hyman has stated in interviews that he takes more than 50 supplements daily. The list below is sourced from his books Young Forever (2023) and The UltraWellness Solution, as well as podcast appearances on The Doctor's Farmacy, The Tim Ferriss Show, and Dhru Purohit's podcast.

Core Daily Supplements (Directly Stated)

Omega-3 fatty acids. Hyman has described taking 2-4 g of combined EPA/DHA daily from fish oil. A 2019 Cochrane review of 79 randomized controlled trials found that omega-3 supplementation reduced cardiovascular events by approximately 15% relative to placebo, with dose-dependent effects on triglycerides [4].

Magnesium glycinate. He cites magnesium as one of the most common nutrient deficiencies in adults. A 2018 analysis in Nutrients covering 48 studies found that approximately 45% of Americans do not meet the estimated average requirement for magnesium, and deficiency correlates with elevated inflammatory markers [5].

Vitamin D3 with K2. Hyman has described targeting a serum 25-hydroxyvitamin D level of 60-80 ng/mL, substantially above the conventional sufficient threshold of 20 ng/mL. He takes 5,000-10,000 IU D3 paired with 100-200 mcg of vitamin K2 (MK-7 form) to direct calcium to bone rather than arterial walls.

Methylated B vitamins. Given the high prevalence of MTHFR polymorphisms, Hyman uses methylfolate (5-MTHF) and methylcobalamin rather than folic acid and cyanocobalamin. Approximately 40-60% of the population carries at least one MTHFR C677T variant that reduces enzyme activity, according to NIH genetics data [6].

CoQ10 (ubiquinol form). He has cited 200-400 mg daily. Ubiquinol bioavailability exceeds standard ubiquinone by roughly 3-fold in subjects over 50, based on a comparative pharmacokinetic study in Regulatory Toxicology and Pharmacology [7].

NMN or NR for NAD+ support. Hyman has discussed nicotinamide mononucleotide (NMN) supplementation to support NAD+ levels, which decline roughly 50% between ages 40 and 60 according to tissue studies cited in a 2020 Nature Metabolism review [8]. Human trial data remain early: a 2022 randomized trial in Nature Aging (N=30) found 250 mg/day NMN raised blood NAD+ by 38% over 10 weeks without significant adverse events [9].

Resveratrol and pterostilbene. Hyman has described taking both as sirtuin-pathway activators. Evidence for longevity benefit in humans remains limited compared with animal data; this is an area where he appears to make inferences from preclinical science.

Spermidine. He references spermidine for autophagy induction, citing the Graz cohort data. A 2021 randomized trial in Cell Reports Medicine (N=100) found that 1.2 mg/day spermidine over 12 months improved memory performance in older adults at risk for dementia (P<0.05) [10].

Berberine. Hyman has described using berberine (500 mg, 2-3x daily) for its insulin-sensitizing and AMPK-activating properties. A 2012 meta-analysis in Evidence-Based Complementary and Alternative Medicine covering 14 RCTs found berberine reduced fasting blood glucose by a mean of 19.83 mg/dL compared with placebo [11].

Probiotics and prebiotics. He takes multi-strain probiotics and uses prebiotic fibers (partially hydrolyzed guar gum, inulin) to support the gut microbiome, which he considers a core longevity organ.

Lithium orotate (low-dose). Hyman has mentioned micro-dose lithium orotate (5-10 mg) based on epidemiological data linking naturally occurring lithium in drinking water with reduced all-cause mortality and dementia rates.

Alpha-lipoic acid, acetyl-L-carnitine, and PQQ. This trio is discussed in his books as mitochondrial support. Each targets a distinct step in mitochondrial energy production and antioxidant recycling.

Inferred Additions (Not Directly Confirmed)

Based on the overall logic of his publicly described protocol and standard functional medicine practice patterns at the UltraWellness Center, Hyman likely uses curcumin with piperine, quercetin, and astaxanthin, though he has not explicitly confirmed dosages. These are labeled as inference.

Hormone Optimization: Testosterone and DHEA

Testosterone Replacement Therapy

Hyman has discussed testosterone replacement therapy (TRT) openly in podcast interviews, framing it as restoring levels to a physiologically youthful range rather than supraphysiologic enhancement. He has not publicly disclosed the specific formulation (injectable testosterone cypionate, transdermal gel, or pellet), delivery route, or dosage.

The clinical rationale is supported by established endocrinology. Total testosterone in men declines at roughly 1-2% per year after age 30 [12]. The 2023 Endocrine Society Clinical Practice Guideline on testosterone therapy in adult men notes that "men with unequivocally low serum testosterone concentrations and consistent symptoms may benefit from testosterone therapy" and lists improved body composition, bone density, and sexual function as documented outcomes [13].

A key caveat: the 2023 TRAVERSE trial (N=5,246, published in NEJM) found that TRT in middle-aged men with hypogonadism did not significantly increase major adverse cardiovascular events compared with placebo over a mean follow-up of 33 months, addressing a long-standing safety concern [14].

DHEA Supplementation

Hyman has stated he takes DHEA, the adrenal precursor to both testosterone and estrogen. DHEA-S declines approximately 80% between ages 25 and 75. He has described testing serum DHEA-S and adjusting dose to restore levels to a youthful reference range, typically targeting 200-350 mcg/dL for men.

The FDA classifies DHEA as a dietary supplement in the United States, so it does not require a prescription. At doses of 25-50 mg/day, DHEA is generally well-tolerated in older adults, though androgenic side effects (acne, hair thinning) are possible at higher doses.

Growth Hormone and Peptide Secretagogues

Hyman has discussed the decline in growth hormone with age and has referenced peptide secretagogues. He has not confirmed using recombinant human growth hormone (rhGH) directly, which would require a prescription and is approved only for diagnosed adult growth hormone deficiency. This protocol element is inferred, not confirmed.

Growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormone analogs such as sermorelin and CJC-1295 are commonly discussed in the functional medicine longevity space. Their clinical trial database is far smaller than that for TRT. Hyman has not publicly confirmed specific peptide names or dosages for this category.

Peptide Therapy: BPC-157 and Tissue Repair

Hyman has mentioned BPC-157 (Body Protection Compound 157) in podcast content, describing it as a peptide with systemic tissue-repair properties. BPC-157 is a 15-amino-acid synthetic peptide derived from a human gastric protein. It currently has no FDA approval and is classified as a research compound.

Preclinical data in rodents show accelerated tendon and ligament healing, gastroprotective effects, and anti-inflammatory activity. Human trial data are extremely limited. A 2018 review in Current Pharmaceutical Design summarized animal data suggesting BPC-157 modulates nitric oxide synthesis and angiogenesis, but acknowledged the absence of completed human RCTs [15]. Hyman's use, if confirmed, would be off-label and outside any approved indication.

BPC-157 was placed on the FDA's list of bulk drug substances that may not be compounded in April 2024, which limits its clinical availability in the United States. Patients interested in this compound should discuss the regulatory and safety status with a physician before use.

Exercise: Zone 2 Cardio, Strength, and VO2 Max Focus

Zone 2 Aerobic Training

Hyman has been consistent across multiple interviews in citing Zone 2 cardio (approximately 60-70% of maximum heart rate, sustainable conversation pace) as the foundation of his exercise protocol. He describes training 4-5 sessions per week, typically 45-60 minutes per session on a stationary bike or outdoors.

Zone 2 training specifically targets mitochondrial biogenesis by maximizing fat oxidation at the cellular level. A 2021 review in Cell Metabolism by Iñigo San-Millán and George Brooks identified lactate as a central signaling molecule in Zone 2 metabolism and showed that chronic Zone 2 training improves mitochondrial enzyme activity in skeletal muscle by 20-40% in trained adults [16].

Strength Training

He describes 2-3 resistance training sessions per week targeting muscle preservation. Skeletal muscle mass declines roughly 3-8% per decade after age 30, accelerating after 60, a process termed sarcopenia [17]. Preserving muscle mass is associated with lower all-cause mortality independent of cardiovascular fitness. A 2022 BMJ meta-analysis (N=1,957,004) found that muscle-strengthening activity was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, and cancer mortality [18].

VO2 Max as a Longevity Biomarker

Hyman has cited VO2 max as the single strongest predictor of longevity he tracks. A 2018 JAMA Network Open study (N=122,007) found that patients in the lowest cardiorespiratory fitness quintile had an all-cause mortality hazard ratio of 5.04 compared with those in the elite fitness quintile, a stronger predictor than smoking, hypertension, or diabetes [19].

Sleep Optimization

Hyman has stated that 8 hours of sleep is non-negotiable in his protocol. He uses an Oura Ring to track sleep stages and heart rate variability (HRV). He has described a strict 10 p.m. To 6 a.m. Sleep window, no screens after 9 p.m., a room temperature of approximately 65-67°F, and blackout curtains.

Sleep deprivation of even modest degree (6 hours vs. 8 hours) raises fasting glucose, lowers testosterone, and increases cortisol. A 2020 randomized crossover trial in Journal of Clinical Endocrinology and Metabolism (N=34) found that one week of sleep restriction to 5 hours per night reduced testosterone levels by 10-15% in healthy young men [20].

Stress Regulation and Mental Performance

Meditation and HRV Training

Hyman has described a daily meditation practice of 20 minutes using Transcendental Meditation (TM) technique. He monitors HRV as a proxy for autonomic nervous system recovery. Higher resting HRV is consistently associated with lower cardiovascular mortality in population data.

Sauna and Cold Exposure

He has discussed both sauna bathing (4-7x weekly, Finnish dry sauna at 80-100°C, 20 minutes per session) and cold plunges or cold showers. The KIHD prospective cohort study (N=2,315, Finland) found that 4-7 sauna sessions per week were associated with a 40% reduction in all-cause mortality and a 50% reduction in sudden cardiac death over 20 years compared with once-weekly sauna use (P<0.001) [21].

Advanced Lab Testing and Biomarker Tracking

Hyman has been explicit that his protocol is guided by quarterly or semi-annual lab panels rather than population norms. He has described ordering or reviewing:

• Fasting insulin (personal target <5 mcIU/mL)
• HbA1c (target <5.2%)
• ApoB (target <80 mg/dL)
• Lp(a) at baseline
• Homocysteine (target <7 mcmol/L)
• hsCRP (target <0.5 mg/L)
• IGF-1 (to calibrate GH axis)
• Comprehensive hormone panel (total and free testosterone, DHEA-S, estradiol, SHBG, cortisol AM)
• Nutrient levels: 25-OH vitamin D, RBC magnesium, zinc, ferritin, B12
• Epigenetic age tests (Horvath methylation clock or Levine PhenoAge)

This biomarker-driven, treat-to-target approach is consistent with the American College of Preventive Medicine's guidance on personalized preventive medicine, though few of these specific targets have been validated in prospective cardiovascular outcomes trials.

Cognitive Longevity Interventions

Hyman has discussed brain health as a distinct pillar of his protocol. In his book The UltraMind Solution, he describes addressing the "seven keys" to brain health, several of which map to biochemical interventions.

Specific agents he has mentioned for cognitive support include lion's mane mushroom (Hericium erinaceus), phosphatidylserine (100-300 mg/day), and acetyl-L-carnitine. A 2020 Cochrane review found insufficient evidence to recommend any single supplement for dementia prevention in cognitively healthy adults, but phosphatidylserine showed a modest signal for memory in older adults in several smaller trials [22].

He has also referenced methylene blue at low doses as a mitochondrial electron carrier, though he has not confirmed a specific dose or frequency. Human data on methylene blue for cognitive enhancement are limited to very small pilot trials.

What the Science Supports vs. What Remains Speculative

Not every element of Hyman's protocol has the same evidence base. The table below categorizes the interventions by level of human trial support.

| Intervention | Evidence Level | Key Trial or Source | |---|---|---| | Zone 2 exercise | Strong | San-Millán & Brooks 2021, Cell Metabolism [16] | | Strength training | Strong | BMJ meta-analysis 2022 [18] | | Sleep optimization | Strong | Multiple RCTs | | Omega-3 (EPA/DHA) | Moderate-strong | Cochrane 2019 [4] | | Sauna (4-7x/wk) | Moderate | KIHD cohort [21] | | Testosterone (in hypogonadism) | Moderate | TRAVERSE trial [14] | | Berberine (glucose control) | Moderate | Meta-analysis 2012 [11] | | NMN (NAD+ repletion) | Early/limited | Nature Aging 2022 [9] | | Spermidine | Early/limited | Cell Reports Medicine 2021 [10] | | BPC-157 | Preclinical only | No completed human RCTs | | Methylene blue (cognitive) | Preliminary | Pilot studies only |

Physician Perspective: Where Functional Medicine Meets Conventional Evidence

Dr. David Sinclair of Harvard Medical School, whose work on NAD+ and sirtuin biology Hyman has cited extensively, wrote in Lifespan (2019): "Information theory of aging suggests that the loss of epigenetic information is a primary driver of biological aging, and that restoring this information is theoretically reversible." Hyman's heavy use of methylation-supporting nutrients, NAD+ precursors, and epigenetic testing reflects this same hypothesis applied at the clinical level.

The American Academy of Anti-Aging Medicine and the American College of Lifestyle Medicine do not endorse a single specific longevity "stack," but both organizations emphasize that individualized lab-guided intervention outperforms population-average supplementation. The Endocrine Society's 2023 guideline on testosterone therapy [13] represents the closest thing to formal institutional backing for one significant arm of Hyman's approach.

Clinicians reviewing Hyman's protocol for patient education should note that his approach requires significant financial resources (quarterly labs, multiple prescription agents, high-quality supplements), physician oversight for the hormonal components, and a willingness to act on biomarkers that do not yet have trial-validated treatment thresholds.